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1. Introduction
  Malaria continues to pose a serious threat to human 
population of the tropical and subtropical regions. The 
appearance of drug resistant strains of malaria parasite 
has materially worsened this danger, and this has become 
a major stumbling block to economic development and 
tourism in the affected areas[1]. Despite the increasing 
threat of malaria to lives especially in Africa, success 
in controlling the disease is still possible[2]. Different 
approaches have been explored to control malaria 
including vector control methods, chemotherapy, exploring 
evidence of immunity, etc[3]. Chemotherapy is the main 
stay of malarial control. The previously efficacious 
chloroquine has substantially failed as a prophylactic and 
therapeutic antimalarial in many endemic countries of 
Africa, Asia and South America due to a corresponding 
spread of chloroquine resistant Plasmodium berghei 
(P. berghei) strains with mutant alleles for chloroquine 
resistance transporter protein (pfcrt T76) and multidrug 
resistant glycoprotein (pfmdr IY86)[4,5]. Consequently the 
diminished potency of chloroquine above the 25% failure 
in many countries including Nigeria has paved way for 
the use of other antimalarial drugs. Unfortunately, these 
alternative antimalarial drugs including sulfadoxine-
pyrimethamine combination, mefloquine and halofantrine 
are also resisted by P. falciparium[6,7]. Combination drug 
regimens have become the practice of choice because of 
their increased therapeutic efficacy over monotherapy and 
the other benefits including decreased cytotoxicity, delay 
or prevention of the development of drug resistance[8]. It 
is widely reported that artemisinins in combination with 
other antimalarials have distinct mode of action and remain 
the only anti-malarial regimens, though resistance to 
artemisinin monotherapy is emerging[9,10]. However, most 
of these regimens are administered in low doses and it 
Objective: To determine the suppressive and curative activity of aqueous leaf extract 
of Ageratum conyzoides (A. conyzoides) in combination with chloroquine and artesunate, 
respectively against Plasmodium berghei infection in mice. Methods: Using malaria (Plasmodium 
berghei) infected albino mice of both sexes, aqueous extracts of A. conyzoides in combination 
with chloroquine and artesunate were tested for antimalarial activity, respectively. Four-day 
suppressive test and Rane’s curative test were carried out. Results: Suppressive tests showed 
significant dose dependent reduction in parasitemia level produced by the extract-chloroquine 
and extract-artesunate combinations. Suppressive activities of both extract-drug combinations 
were greater than the individual drugs alone. Extract-chloroquine (100:5) produced the highest 
suppressive effect (98% suppression). Curative tests showed absolute survival in two extract-
drug combinations. Two extract-drug combinations produced higher curative effects than 
the individual drugs alone. The highest dose combinations of extract-chloroquine (100:5) and 
extract-artesunate (100:5) produced absolute parasitemia clearance (cure) in the infected mice. 
Conclusions: The study indicated that aqueous extract of A. conyzoides had the ability to 
potentiate the antimalarial activity of chloroquine and artesunate against induced plasmodiasis in 
mice. It contributes a lot in the malaria endemic and poverty stricken tropics.
Ukwe Chinwe V et al./Asian Pacific Journal of Tropical Medicine (2010)943-947944
is difficult in implementation especially in rural areas of 
developing countries due to affordability and accessibility 
constrains[11] 
  This scenario has re-awakened interest in the exploration 
of medicinal plants from which antimalarials such as 
quinine and artemisinin were found[12]. Plants, undoubtedly, 
play an important  role in African indigenous system of 
medicine, especially in the rural areas with limited access 
to modern medical and health facilities[13]. Herbal drugs 
or their extracts are prescribed widely, even when their 
biological active compounds are unknown[14]. World 
Health Organization (WHO) estimates that up to 80% of the 
African population use traditional medicine especially 
plant remedies in the management of diseases including 
malaria[15]. In Nigeria, mono or polyherbal mixtures have 
been employed in treatment of malaria symptoms[16].
  Ageratum conyzoides (A. conyzoides) (Family: Asteraceae) 
is one of such plants with folkloric reputation as antimalarial 
agent. It is an annual herbaceous plant widely distributed 
in the tropics as a herbal weed. Extracts of the plant have 
been used in traditional medicines as remedies against 
wounds and burn, microbial infections, arthrosis, headache, 
inflammation dyspnea, pain, asthma, spasms, gynaecological 
diseases, leprosy and other skin diseases[17]. In Africa, 
A. conyzoides is also traditionally used to treat fever, 
rheumatism, headache, malaria, pneumonia, wounds, burns 
and colic[18]. An earlier pharmacology study of the plant 
showed significant positive antimalarial activity in rats[19].
  This study was aimed at evaluating the antimalarial 
activity of the aqueous leaf extract of A. conyzoides when in 
combination with standard antimalarials: chloroquine and 
artesunate, respectively.
2. Materials and methods
2.1. Chemicals and test agents
  Methanol, n-hexane, Chloroform, Tween 80 (all Sigma 
Aldrich, Germany), Chloroquine (Neimeth®, Nigeria), 
Artesunate (Emzor®, Nigeria), distilled water. All reagents 
were of analytical grade. 
2.2. Plant material                                                                                          
  Fresh leaves of A. conyzoides were collected from wild 
plants growing around farmlands in University of Nigeria, 
Nsukka in September 2008. The plant was identified by 
Mr. Paulinus Ugwuozor, a taxonomist in the Department 
of Botany, University of Nigeria, Nsukka. A voucher 
specimen was preserved at the herbarium of Pharmacognosy 
Department, University of Nigeria, Nsukka.
2.3. Preparation of extract
  The leaves of the plant were cleaned, shade dried for 
four days and pulverized to coarse powder. One kilogram 
(1 kg) of the dried leaf powder was extracted with 4 liters 
of distilled water by cold maceration method. The extract 
was preserved in a refrigerator and later lyophilized at 
the National Institute of Pharmaceutical Research and 
Development (NIPRD), Abuja, Nigeria. The resultant dried 
extract was designated as aqueous extract of A. conyzoides 
and kept at cool storage before use.
2.4. Animals
  Adult male and female Swiss albino mice weighing 
between 18-25 g obtained from the Animal Facility Centre 
of NIPRD were used. The animals were observed under light/
dark cycle in metabolic cages in a well ventilated [average 
room temperature of (28依4)曟] rodent cubicle. They were fed 
with mice pellet diet and given free access to clean drinking 
water. The animals were kept in well disinfected rooms 
(to avoid any form of parasite infections) and allowed to 
acclimatize for two weeks before the start of the experiment. 
All the animals were conducted according to regulations of 
the National Institute of Health Guide for Care and Use of 
Laboratory Animals. 
2.5. Rodent parasite
  Chloroquine sensitive P. berghei  (NK65 Strain) was sourced 
from the National Institute for Medical Research (NIMR), 
Lagos and maintained in NIPRD by serial passaging in mice.
2.6. Antiplasmodial activity
2.6.1. Suppressive effect of A. conyzoides separately combined 
with chloroquine and artesunate
  The suppressive effect of aqueous extract of A. 
conyzoides  in combination with chloroquine and 
artesunate, respectivelyagainst P. berghei infection in 
mice was determined using Peters’ 4-day suppression 
test procedure[20]. A donor mouse densely infected with 
parasites was anaesthetized with chloroform and the blood 
was collected through cardiac puncture. The presence of 
parasitemia was established by microscopic examination 
of a thin blood film. One mL blood was diluted with 
normal saline to 20 mL. A total of 0.2 mL diluted blood was 
injected intraperitoneally into 54 healthy mice. The infected 
animals were randomly divided into 9 groups namely three 
A. conyzoides-chloroquine groups, three A. conyzoides-
artesunate groups, chloroquine group, artesunate group and 
negativecontrol group. The animals were treated shortly 
after inoculation on day zero (Do). A. conyzoides-chloroquine 
groups were given chloroquine at 5 mg/kg concurrently with 
A. conyzoides at 25, 50 and 100 mg/kg, p.o., respectively. 
A. conyzoides-artesunate groups were given artesunate at 
2 mg/kg and A. conyzoides at different dosage as above. 
Chloroquine group received chloroquine at 5 mg/kg. 
Artesunate group received artesunate at 2 mg/kg. And negative 
control group received 0.2 mL of distilled water. Oral route 
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was used for all administration. Treatment continued daily 
(D1-D3) until D4 when thin film from the tail blood of each 
mouse was made on a microscopic slide. The slides were 
stained with leishman stain, and examined under the 
microscope. Parasitemia level was determined by counting 
average number of parasites in 10 fields of at least 1 000 
erythrocytes. Percentage parasitemia inhibition was then 
calculated.
2.6.2. Combined curative effect of  A. conyzoides separately 
combined with chloroquine and artesunate
  Rane’s curative test procedure was used[21]. The inoculation 
and treatment protocols used for Rane test were similar to 
suppressive test procedure, except that treatment started 
on the D3, that is, 72 hours after infection was established. 
The number of animals and the groups were the same as 
above. On D3, pretreatment blood smear of each mouse was 
made and examined under the microscope. A. conyzoides-
chloroquine groups received 10 mg/kg, p.o. of chloroquine, 
and A. conyzoides at 25, 50, and 100 mg/kg, p.o., respectively. 
A. conyzoides-artesunate groups received 4 mg/kg of artesunate, 
and A. conyzoides at different dosage as above. Chloroquine 
group received chloroquine at 10 mg/kg. Artesunate group 
received artesunate at 4 mg/kg. And negative control group 
received 0.2 mL of distilled water. Treatment continued 
daily (D4-D6) until D7 when post treatment blood smears of 
each mouse was made on a microscopic slide and examined 
microscopically. The blood smear was also collected on 
the D14 and examined microscopically. The animals were 
observed for 30 days and the mean survival time of each 
group was recorded[22].
2.7. Statistical analysis
  Results were expressed as mean依standard errors of mean 
(SEM). Analysis of variance (ANOVA) was used to analyze 
differences among groups. Subgroup analysis (post hoc) was 
conducted using LSD. Then a 2 tailed significant of 0.05 level 
was used as significant difference.
3. Results
3.1. Suppressive tests 
  Table 1 showed results of suppressive tests by artesunate, 
chloroquine and Ageratum extract-drug combinations. 
Percentage suppression showed significant (P<0.05) 
suppression for all treatments compared to control. 
Suppressive effects produced by the extract-drug 
combinations were higher than chloroquine and artesunate 
alone. Also the suppressive effects of extract-chloroquine 
combination were higher than those produced by extract- 
artesunate combination at equivalent dose combinations. 
All suppressive effects were dose-dependent in the extract-
drug combinations.
3.2. Curative tests
  Curative effects test showed absolute survival times for 
all test treatments including extract-drug combinations. 
Duration of survival was similar to all treatments as all 
animals survived after 30 days. All animals in the control 
died before the 12th day. Cure from plasmodium parasitemia 
was significant (P<0.05) in all treatments when compared 
with control. A. conyzoides -chloroquine (100:10) and A. 
conyzoides -artesunate (100:4) produced absolute parasitemia 
clearance (0 cell/mL of P. berghei) before the 14th day. 
Artesunate produced a better clearance than chloroquine on 
day 7 and 14 of treatment.
4. Discussion
  This study had demonstrated the inherent ability of 
the aqueous leaf extract of A. conyzoides to potentiate 
the suppressive and cure rate of chloroquine as well as 
artesunate in vivo in mice infected with P. berghei. An 
earlier study had shown the positive plasmodial suppressive 
activity of A. conyzoides[19] and agents with suppressive 
activity against P. berghei for antimalarial activity[23]. 
  Co-administration of A. conyzoides with prophylactic dose of 
chloroquine (5 mg/kg), and maintenance dose of artesunate 
(2 mg/kg), resulted in dose dependent chemosuppression of 
parasitemia, that was greater than the effects of chloroquine, 
artesunate or selected doses of the plant extract used singly 
in P. berghei infection in mice[19]. This additive effect was 
seen in all the combination doses used. The increase in 
parasitemia clearance with increase in dose of A. conyzoides 
in each combination showed there were probably no 
antagonistic effects produced by the herb-drug combination.
  In the curative test, co-administration of selected doses of 
the aqueous extract with therapeutic dose of chloroquine, 
though did not totally clear the parasite on the day 7 post 
treatment, reduced the parasitemia count to much lower 
levels compared to chloroquine alone. Extract-artesunate 
combinations also produced excellent parasitemia reduction, 
three days post-treatment (Day 7) compared to reduction 
of artesunate drug alone. These may suggested potent 
synergistic anti-malarial activity between the extract and 
these standard drugs, chloroquine and artesunate. 
  Till day 14, no form of recrudescence was seen in all 
the drug combinations, as parasitemia clearance was 
consistent till the 14th day. This showed potent and long 
term antimalarial effect of the herb-drug combinations. 
With curative dose of artesunate (4 mg/kg), the combination 
totally cleared the parasitemia at extract dose of 100 mg/kg on 
day 7, compared to artesunate or chloroquine alone. The 
combination (extract-artesunate, 100:4) maintained the 
absolute cure rate on day 14 and prolonged recrudescence 
time unlike artesunate alone which had already shown 
recrudescence on day 14. This is in line with reports 
of Iwalokun et al [24]. This is one of the reasons for 
initiating artemisinin combination therapy (ACT) in acute 
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uncomplicated malaria. Thus a combination of extract of 
A. conyzoides and artesunate would produce excellent cure 
rates and reduce recrudescence. The mean survival time 
of the treated groups in both cases was more than 4 weeks 
unlike that of the untreated control which died before two 
weeks. It further confirmed the fact that the herb-drug 
combinations were effective in parasitemia reduction to 
non-fatal levels even after long periods of post-treatment. 
  The findings of this study are very similar with other 
reports on other antimalarial herb-drug interactions that 
showed potentiating effect of herbs on the antimalarial action 
of some standard drugs[25-29]. The potentiating antimalarial 
effect of the extract of A. conyzoides on the antimalarial 
activity of chloroquine and artesunate, might probably be 
due to prolongation of elimination half life of these drugs 
as reported[25], or synergistic action with chloroquine 
in inhibiting hematin formation as reported[30,31]. These 
assumptions however form the basis of our future research 
on this plant. 
  This study demonstrated the ability of aqueous leaf extract 
of A. conyzoides to potentiate the antimalarial activities 
of chloroquine and artesunate when used as an adjuvant. 
Further development of Ageratum for this purpose would 
no doubt provide cost effective strategy of malaria control 
especially in developing countries where poor affordability 
and accessibility of orthodox drugs are primary barrier to 
healthcare. More studies are needed to elucidate the exact 
mechanism of action of A. conyzoides coupled with toxicity 
testing for the assessment of its drug-extract efficacy and 
safety.
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